The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease

被引:18
|
作者
Lee, Hye Won [1 ]
Chung, Sook Hee [2 ]
Moon, Chang Mo [3 ]
Che, Xiumei [4 ]
Kim, Seung Won [1 ]
Park, Soo Jung [1 ]
Hong, Sung Pil [1 ]
Kim, Tae Il [1 ]
Kim, Won Ho [1 ]
Cheon, Jae Hee [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
[2] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea
[3] Ewha Womans Univ, Dept Internal Med, Sch Med, 1071 Anyangcheon Ro, Seoul, South Korea
[4] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Seoul 120749, South Korea
基金
新加坡国家研究基金会;
关键词
INTESTINAL BEHCETS-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; ENDOSCOPIC ACTIVITY; ADAPTIVE IMMUNITY; RANDOMIZED-TRIAL; SES-CD; INTERLEUKIN-12; VALIDATION; CYTOKINE;
D O I
10.1097/MD.0000000000003772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic variants in IL12B, encoding the p40 subunit common in interleukin-12 (IL-12) and interleukin-23, were identified as the susceptibility loci for inflammatory bowel disease (IBD). This study aimed to identify the correlation of serum IL-12B expression with disease activity in patients with IBD and evaluate the possibility of IL12B as a biomarker for assessing inflammatory status in IBD. A total of 102 patients with IBD, including 38, 32, and 32 patients with Crohn's disease (CD), ulcerative colitis (UC), and intestinal Behc, et's disease (intestinal BD), respectively, were included. The clinical and laboratory data from the patients were collected at the time of serum IL-12B measurement. Serum IL-12B levels were measured using an enzyme-linked immunosorbent assay. The median IL-12B levels in patients with CD, UC, and intestinal BD were significantly higher than those in controls (1.87, 2.74, and 2.73 pg/mL, respectively, vs. 1.42 pg/mL, all P < 0.05). IL-12B concentrations were associated with disease activity in patients with UC and intestinal BD but not in those with CD. IL-12B levels were increased with increasing disease activity in patients with UC (P < 0.001). Likewise, patients with active intestinal BD had higher IL-12B levels than those without active disease (P = 0.008). IL-12B levels were correlated with the endoscopic disease activity of UC (P = 0.002) and intestinal BD (P = 0.001) but not that of CD. Serum IL-12B levels were significantly correlated with clinical and endoscopic disease activity in patients with UC and intestinal BD, suggesting its potential use as a biomarker for assessing disease activity in these patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease
    Miranda-Garcia, Pablo
    Chaparro, Maria
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (08): : 508 - 515
  • [22] Association of IL-12B Genetic Polymorphism with the Susceptibility and Disease Severity of Ankylosing Spondylitis
    Wong, Ruey-Hong
    Wei, James Cheng-Chung
    Huang, Chun-Huang
    Lee, Hong-Shen
    Chiou, Shang-Yan
    Lin, Shin-Hua
    Cai, Yan-Wei
    Hung, Pei-Hsuan
    Wang, Ming-Fuu
    Yang, Shun-Fa
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (01) : 135 - 140
  • [23] Increased Expression of IL-12b mRNA Transcribed From Risk Haplotype for Crohn's Disease in Stimulated Monocytes
    Kimura, Tomoya
    Kakuta, Yoichi
    Kinouchi, Yoshitaka
    Negoro, Kenichi
    Takahashi, Seiichi
    Endo, Katsuya
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2010, 138 (05) : S676 - S676
  • [24] Association of IL-12A and IL-12B polymorphisms with Alzheimer's disease susceptibility in a Han Chinese population
    Zhu, Xi-Chen
    Tan, Lan
    Jiang, Teng
    Tan, Meng-Shan
    Zhang, Wei
    Yu, Jin-Tai
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 274 (1-2) : 180 - 184
  • [25] Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity
    Brinar, Marko
    Cleynen, Isabelle
    Coopmans, Tamara
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    GUT, 2010, 59 (12) : 1728 - 1729
  • [26] Increased expression of IL-16 in inflammatory bowel disease
    Seegert, D
    Rosenstiel, P
    Pfahler, H
    Pfefferkorn, P
    Nikolaus, S
    Schreiber, S
    GUT, 2001, 48 (03) : 326 - 332
  • [27] Expression of IL-21 in rats with inflammatory bowel disease
    Mao, J. N.
    Shen, Y. S.
    Luo, X. Y.
    Zhi, Y. L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17322 - 17328
  • [28] The impact of inflammatory bowel disease and disease activity on patients' sexuality
    Szymanska, E.
    Kisielewska, L.
    Kotkowicz-Szczur, M.
    Kisielewski, R.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1025 - i1025
  • [29] Eating Patterns and Disease Activity in Patients With Inflammatory Bowel Disease
    DeFilippis, Ersilia
    Tabani, Saniya
    Warren, Ryan
    Webb, Colleen
    Patel, Priyanka
    Chabouni, Fatiha
    Christos, Paul
    Bosworth, Brian
    Scherl, Ellen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S473 - S473
  • [30] Disease activity related dysbiosis in inflammatory bowel disease patients
    Grasman, M. E.
    van der Borden, R. J.
    Budding, A. E.
    Eck, A.
    de Boer, N. K.
    Bouma, G.
    Savelkoul, P. H.
    van Bodegraven, A. A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S484 - S484